Catalyst Crew Technologies Acquired by Inversiones Long 33 | Healthcare M&A Deal

Inversiones Long 33 has acquired Catalyst Crew Technologies, a healthcare IT business in Nevada, for an undisclosed amount. Catalyst Crew Technologies develops AI-based healthcare analytics and diagnostic support technologies, including CardioAI, PulmoAI, and NeuroAI registrations. The acquisition supports Inversiones Long 33 healthcare M&A goals by transferring intellectual property rights and related know-how used for clinical decision support. Inversiones Long 33 acquisitions are categorized as other acquisition and private equity acquisition, with deal status announced and size undisclosed. An intellectual property assignment agreement dated April 7, 2026 covers worldwide rights to use, modify, license, and enforce the registered AI healthcare technology.